Skip to main content

and
  1. No Access

    Article

    Epiregulin confers EGFR-TKI resistance via EGFR/ErbB2 heterodimer in non-small cell lung cancer

    Epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs) are effective against non-small cell lung cancer (NSCLC) with EGFR-activating mutations. The mechanisms underlying EGFR-TKI resistance are n...

    Shiqi Ma, Lu Zhang, Yuan Ren, Wei Dai, Tingqing Chen, Li** Luo, Juan Zeng in Oncogene (2021)

  2. No Access

    Article

    Microenvironmental oxygen pressure orchestrates an anti- and pro-tumoral γδ T cell equilibrium via tumor-derived exosomes

    γδ T cells are a unique lymphocyte population that have been reported to have either anti- or pro-tumoral functions in several cancer types, but the mechanisms are underinvestigated. Exosomes, initially consid...

    Ling Li, Bangrong Cao, **nhua Liang, Shun Lu, Huaichao Luo, Zhaohui Wang in Oncogene (2019)